Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.

Ralf Schreck, P. Rieber, Patrick A. Baeuerle · The EMBO Journal · 1991 · 3.8K citations · Full text

Life Sciences, Immunology, Molecular Biology +11

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Alain Schotte, Paul Janssen, W Gommeren et al. · Psychopharmacology · 1996 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

Paul A. J. Janssen, C. J. E. Niemegeers, F. Awouters et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 468 citations

Medicine, Pharmacology, Pharmacotherapy +14

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6

Steve Zalcman, Julia M. Green-Johnson, Linda Murray et al. · Brain Research · 1994 · 438 citations

Life Sciences, Immunology, Neuroscience +12

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

Michaël Maes, Eugène Bosmans, Joseph R. Calabrese et al. · Journal of Psychiatric Research · 1995 · 385 citations

Pharmacy, Neuroscience, Psychiatry +12